搜索临床试验以:Interval Training
总计12372个结果
-
Merck Sharp & Dohme LLCAriad Pharmaceuticals完全的
-
Cancer Research and Biostatistics Clinical Trials...Novartis Pharmaceuticals; University of Arizona; Providence Cancer Center, Earle A. Chiles Research...完全的
-
Ottawa Hospital Research InstituteSanofi; Pfizer; Hoffmann-La Roche; Ottawa Regional Cancer Foundation终止
-
Massachusetts General HospitalSanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech, Inc.终止
-
Shahid Beheshti University of Medical Sciences未知
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); San Francisco AIDS Foundation; Lifelong... 和其他合作者招聘中
-
University of Maryland, College ParkNational Institute of Mental Health (NIMH); University of Michigan; Seattle Children's Hospital; Children's National Research Institute招聘中
-
Bristol-Myers Squibb完全的乳腺癌中国, 俄罗斯联邦, 美国, 意大利, 阿根廷, 澳大利亚, 奥地利, 比利时, 巴西, 加拿大, 智利, 哥伦比亚, 捷克语, 丹麦, 芬兰, 法国, 德国, 香港, 爱尔兰, 大韩民国, 墨西哥, 荷兰, 波兰, 葡萄牙, 波多黎各, 罗马尼亚, 新加坡, 西班牙, 瑞士, 台湾, 火鸡, 英国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)主动,不招人去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 转移性前列腺癌美国
-
Nathan Pennell, MD, PhDNational Cancer Institute (NCI)完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)终止透明细胞肾细胞癌 | 转移性透明细胞肾细胞癌 | III 期肾细胞癌 AJCC v8 | 不可切除的肾细胞癌 | IV 期肾细胞癌 AJCC v7美国
-
SCRI Development Innovations, LLCAstraZeneca; Genentech, Inc.完全的
-
Onofre, Aurora Pujol, M.D.Ministerio de Sanidad, Servicios Sociales e Igualdad; Fundacion Hesperia完全的
-
University of Massachusetts, WorcesterGenentech, Inc.; Millennium Pharmaceuticals, Inc.终止
-
Hoffmann-La Roche完全的非鳞状非小细胞肺癌美国, 法国, 奥地利, 丹麦, 意大利, 西班牙, 德国, 墨西哥, 荷兰, 日本, 巴西, 希腊, 阿根廷, 斯洛伐克, 黎巴嫩, 比利时, 阿曼, 阿拉伯联合酋长国
-
M.D. Anderson Cancer CenterEli Lilly and Company完全的
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech, Inc.完全的
-
University of SaskatchewanCanadian Institutes of Health Research (CIHR)完全的
-
Annick DesjardinsTactical Therapeutics, Inc.终止恶性神经胶质瘤(WHO III 级或 IV 级)美国
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation完全的
-
AeskuLab Pathology PragueInstitute of Biostatistics and analyses, Ltd.完全的
-
University Hospital TuebingenUniversity Hospital of Cologne完全的Antibiotic Selection Pressure德国
-
Stanford UniversityUnited States Department of Defense; Department of Health and Human Services; Food and Drug Administration... 和其他合作者终止
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
NorthShore University HealthSystem完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)招聘中
-
AbbVie (prior sponsor, Abbott)Abbott Japan Co.,Ltd完全的
-
AbbVieIQVIA, formerly Quintiles完全的